CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 35  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0718
LYS 10.0343
GLU 20.0290
LEU 30.0277
ARG 40.0181
CYS 50.0096
GLN 60.0163
CYS 70.0150
ILE 80.0090
LYS 90.0136
THR 100.0129
TYR 110.0094
SER 120.0092
LYS 130.0093
PRO 140.0077
PHE 150.0042
HIS 160.0134
PRO 170.0091
LYS 180.0085
PHE 190.0062
ILE 200.0057
LYS 210.0113
GLU 220.0102
LEU 230.0070
ARG 240.0184
VAL 250.0141
ILE 260.0112
GLU 270.0488
SER 280.0235
GLY 290.0679
PRO 300.0633
HIS 310.0161
CYS 320.0139
ALA 330.0526
ASN 340.0138
THR 350.0278
GLU 360.0168
ILE 370.0149
ILE 380.0111
VAL 390.0035
LYS 400.0122
LEU 410.0097
SER 420.0150
ASP 430.0350
GLY 440.0323
ARG 450.0246
GLU 460.0172
LEU 470.0054
CYS 480.0080
LEU 490.0119
ASP 500.0169
PRO 510.0204
LYS 520.0193
GLU 530.0115
ASN 540.0084
TRP 550.0071
VAL 560.0104
GLN 570.0096
ARG 580.0120
VAL 590.0099
VAL 600.0099
GLU 610.0199
LYS 620.0187
PHE 630.0104
LEU 640.0229
LYS 650.0185
ARG 660.0197
ALA 670.0221
GLU 680.0144
ASN 690.0718

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.